Michael A. Panzara, Chief Medical Officer at Wave Life Sciences Ltd. (WVE), sold 2,981 shares at $7.85 ($23K) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Scheduled sale ($23k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WVE | SELL | 2021-02-18 | $31K | — | Filing → |
| WVE | SELL | 2019-07-09 | $153K | — | Filing → |
| WVE | SELL | 2019-03-11 | $336K | — | Filing → |